Silencing of long chain noncoding RNA paternally expressed gene (PEG10) inhibits the progression of neuroblastoma by regulating microRNA-449a (miR-449a)/ribosomal protein S2 (RPS2) axis

References

• Valter K, Zhivotovsky B, Gogvadze V. Cell death-based treatment of neuroblastoma. Cell Death Dis. 2018;9:113.
   PubMed Web of Science ®Google Scholar
• Nagaich U. Neuroblastoma cancer in children. J Adv Pharm Technol Res. 2019;10(2):45.
   PubMed Web of Science ®Google Scholar
• Campos Cogo S, Gradowski Farias da Costa Do Nascimento T, de Almeida Brehm Pinhatti F, et al. An overview of neuroblastoma cell lineage phenotypes and in vitro models. Exp Biol Med. 2020;245:1637–1647.
   Web of Science ®Google Scholar
• Mallepalli S, Gupta MK, Vadde R. Neuroblastoma: an Updated Review on Biology and Treatment. Curr Drug Metab. 2019;20(13):1014–1022.
   PubMed Web of Science ®Google Scholar
• Benzekry S, Sentis C, Coze C, et al. Development and Validation of a Prediction Model of Overall Survival in High-Risk Neuroblastoma Using Mechanistic Modeling of Metastasis. JCO Clin Cancer Inform. 2021;5(5):81–90.
   PubMedGoogle Scholar
• Camacho CV, Choudhari R, Gadad SS. Long noncoding RNAs and cancer, an overview. Steroids. 2018;133:93–95.
   PubMed Web of Science ®Google Scholar
• Choudhari R, Sedano MJ, Harrison AL, et al. Long noncoding RNAs in cancer: from discovery to therapeutic targets. Adv Clin Chem. 2020;95:105–147.
   PubMed Web of Science ®Google Scholar
• Taniue K, Akimitsu N, Bagnato VS. The Functions and Unique Features of LncRNAs in Cancer Development and Tumorigenesis. Int J Mol Sci. 2021;23(1):22.
   PubMedGoogle Scholar
• Su Y, Hou W, Zhang C, et al. Long non-coding RNA ZFAS1 regulates cell proliferation and invasion in cervical cancer via the miR-190a-3p/KLF6 axis. Bioengineered. 2022;13(2):3840–3851.
   PubMed Web of Science ®Google Scholar
• Liu Y, Gao S, Du Q, et al. Knockdown of long non-coding RNA metastasis associated lung adenocarcinoma transcript 1 inhibits the proliferation and migration of bladder cancer cells by modulating the microRNA-34a/cyclin D1 axis. Int J Mol Med. 2019;43(1):547–556.
   PubMed Web of Science ®Google Scholar
• Jia P, Wei E, Liu H, et al. Silencing of long non-coding RNA DLX6-AS1 weakens neuroblastoma progression by the miR −513c-5p/ PLK4 axis. IUBMB Life. 2020;72(12):2627–2636.
   PubMedGoogle Scholar
• Zhang Y, Hu Y, Pan A, et al. Long non-coding RNA NHEG1/hsa-miR-665/HMGB1 axis is involved in the regulation of neuroblastoma progression. Bioengineered. 2021;12(2):11584–11596.
   PubMed Web of Science ®Google Scholar
• Zhu K, Wang L, Zhang X, et al. LncRNA HCP5 promotes neuroblastoma proliferation by regulating miR-186-5p/MAP3K2 signal axis. J Pediatr Surg. 2021;56(4):778–787.
   PubMed Web of Science ®Google Scholar
• Li MM, Liu XH, Zhao YC, et al. Long noncoding RNA KCNQ1OT1 promotes apoptosis in neuroblastoma cells by regulating miR-296-5p/Bax axis. FEBS J. 2020;287(3):561–577.
   PubMed Web of Science ®Google Scholar
• Ono R, Kobayashi S, Wagatsuma H, et al. A retrotransposon-derived gene, PEG10, is a novel imprinted gene located on human chromosome 7q21. Genomics. 2001;73(2):232–237.
   PubMed Web of Science ®Google Scholar
• Jiang F, Qi W, Wang Y, et al. lncRNA PEG10 promotes cell survival, invasion and migration by sponging miR-134 in human bladder cancer. Biomed Pharmacothe. 2019;114:108814.
   PubMed Web of Science ®Google Scholar
• Peng W, Fan H, Wu G, et al. Upregulation of long noncoding RNA PEG10 associates with poor prognosis in diffuse large B cell lymphoma with facilitating tumorigenicity. Clin Exp Med. 2016;16(2):177–182.
   PubMed Web of Science ®Google Scholar
• Zhao M, Sun D, Li X, et al. Overexpression of long noncoding RNA PEG10 promotes proliferation, invasion and metastasis of hypopharyngeal squamous cell carcinoma. Oncol Lett. 2017;14(3):2919–2925.
   PubMed Web of Science ®Google Scholar
• Zang W, Wang T, Huang J, et al. Long noncoding RNA PEG10 regulates proliferation and invasion of esophageal cancer cells. Cancer Gene Ther. 2015;22(3):138–144.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Ma X, Sung D, et al. microRNA-449a functions as a tumor suppressor in neuroblastoma through inducing cell differentiation and cell cycle arrest. RNA Biol. 2015;12(5):538–554.
   PubMed Web of Science ®Google Scholar
• Li B, Zhao H, Song J, et al. LINC00174 down-regulation decreases chemoresistance to temozolomide in human glioma cells by regulating miR-138-5p/SOX9 axis. Hum Cell. 2020;33(1):159–174.
   PubMed Web of Science ®Google Scholar
• Zhao J, Su L, Jiang J. Long Non-Coding RNA Paternally Expressed Imprinted Gene 10 (PEG10) Elevates Diffuse Large B-Cell Lymphoma Progression by Regulating Kinesin Family Member 2A (KIF2A) via Targeting MiR-101-3p. Med Sci Monit. 2020;26:e922810.
   PubMed Web of Science ®Google Scholar
• Wang L, Wang Z, and Huang L, et al. MiR-29b suppresses proliferation and mobility by targeting SOX12 and DNMT3b in pancreatic cancer. Anticancer Drugs. 2019;30 (3):281–288.
   PubMed Web of Science ®Google Scholar
• Chen Z, Chen X, Chen P, et al. Long non-coding RNA SNHG20 promotes non-small cell lung cancer cell proliferation and migration by epigenetically silencing of P21 expression. Cell Death Dis. 2017;8(10):e3092–e.
   PubMedGoogle Scholar
• Cheng J, Lou Y, Jiang K. Downregulation of long non-coding RNA LINC00460 inhibits the proliferation, migration and invasion, and promotes apoptosis of pancreatic cancer cells via modulation of the miR-320b/ARF1 axis. Bioengineered. 2021;12(1):96–107.
   PubMed Web of Science ®Google Scholar
• Zhai Z, Mu T, Zhao L, et al. MiR-181a-5p facilitates proliferation, invasion, and glycolysis of breast cancer through NDRG2-mediated activation of PTEN/AKT pathway. Bioengineered. 2022;13(1):83–95.
   PubMed Web of Science ®Google Scholar
• Yu Y, Xiao CH, Tan LD, et al. Cancer-associated fibroblasts induce epithelial-mesenchymal transition of breast cancer cells through paracrine TGF-β signalling. Br J Cancer. 2014;110(3):724–732.
   PubMed Web of Science ®Google Scholar
• Chen J, Huang X, Wang W, et al. LncRNA CDKN2BAS predicts poor prognosis in patients with hepatocellular carcinoma and promotes metastasis via the miR-153-5p/ARHGAP18 signaling axis. Aging (Albany NY). 2018;10(11):3371–3381.
   PubMedGoogle Scholar
• Wei M, Ye M, Dong K, et al. Mass screening for neuroblastoma in infants. Discov Med. 2020;30(160):63–70.
   PubMed Web of Science ®Google Scholar
• Shi T, Morishita A, Kobara H, et al. The Role of Long Non-Coding RNA and microRNA Networks in Hepatocellular Carcinoma and Its Tumor Microenvironment. Int J Mol Sci. 2021;23(1):22.
   PubMedGoogle Scholar
• Liang J, Liu N, Xin H. Knockdown long non-coding RNA PEG10 inhibits proliferation, migration and invasion of glioma cell line U251 by regulating miR-506. Gen Physiol Biophys. 2019;38(4):295–304.
   PubMed Web of Science ®Google Scholar
• Hu S, Cao P, Kong K, et al. MicroRNA-449a delays lung cancer development through inhibiting KDM3A/HIF-1alpha axis. J Transl Med. 2021;19(1):224.
   PubMed Web of Science ®Google Scholar
• Bauer S, Ratz L, Heckmann-Notzel D, et al. miR-449a Repression Leads to Enhanced NOTCH Signaling in TMPRSS2:ERG Fusion Positive Prostate Cancer Cells. Cancers (Basel). 2021;14(1):13.
   PubMedGoogle Scholar
• Chan LS, Lung HL, and Ngan RK, et al. Role of miR-96/EVI1/miR-449a Axis in the Nasopharyngeal Carcinoma Cell Migration and Tumor Sphere Formation. Int J Mol Sci. 2020;213:5495.
   PubMedGoogle Scholar
• Li Z, Hou G. LincRNA-p21 Inhibits Cisplatin-Induced Apoptosis of Human Renal Proximal Tubular Epithelial Cells by Sponging miR-449a. Kidney Blood Press Res. 2021;46(4):495–501.
   PubMed Web of Science ®Google Scholar
• Gao X, Yu L, Zhang J, et al. Silencing of Long Non-Coding RNA LINC01106 Suppresses the Proliferation, Migration and Invasion of Endometrial Cancer Cells Through Regulating the miR-449a/MET Axis. Onco Targets Ther. 2020;13:9643–9655.
   PubMed Web of Science ®Google Scholar
• Yue X, Dong C, Ye Z, et al. LncRNA SNHG7 sponges miR-449a to promote pituitary adenomas progression. Metab Brain Dis. 2021;36(1):123–132.
   PubMed Web of Science ®Google Scholar
• Wang M, Hu Y, Stearns ME. RPS2: a novel therapeutic target in prostate cancer. J Exp Clin Cancer Res. 2009;28(1):6.
   PubMedGoogle Scholar
• Chiao PJ, Shin DM, Sacks PG, et al. Elevated expression of the ribosomal protein S2 gene in human tumors. Mol Carcinog. 1992;5(3):219–231.
   PubMed Web of Science ®Google Scholar
• Kowalczyk P, Woszczynski M, Ostrowski J. Increased expression of ribosomal protein S2 in liver tumors, posthepactomized livers, and proliferating hepatocytes in vitro. Acta Biochim Pol. 2002;49(3):615–624.
   PubMed Web of Science ®Google Scholar
• Wang M, Hu Y, Amatangelo MD, et al. Role of ribosomal protein RPS2 in controlling let-7a expression in human prostate cancer. Mol Cancer Res. 2011;9(1):36–50.
   PubMed Web of Science ®Google Scholar